Kura Oncology (KURA) Reports In-Line Q3 EPS
Tweet
Share
E-mailGet Alerts KURA Hot Sheet
Join SI Premium – FREE
Kura Oncology (NASDAQ: KURA) reported Q3 EPS of ($0.63), in-line with the analyst estimate of ($0.63).
For earnings history and earnings-related data on Kura Oncology (KURA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Reinstates Zoom Video (ZM) at Buy
- CXApp acquires Australian firm EngineRoom in June 2026 deal
- H.C. Wainwright Reiterates Buy Rating on Intensity Therapeutics, Inc. (INTS)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
